Savient Pharma Unveils Ch. 11 Plan
Drug developer Savient Pharmaceuticals Inc. unveiled its Chapter 11 plans in Delaware bankruptcy court Monday, calling for the liquidation of its U.S. and international assets that were not picked up by...To view the full article, register now.
Already a subscriber? Click here to view full article